Cell-matrix Interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules

References

• Aebischer P, Russell PC, Christenson L, Panol G, Monchik JM, Galletti PM. 1986. A bioartificial parathyroid. ASAIO Trans. 32:134–137.
   Google Scholar
• Aebischer P, Goddard M, Signore AP, Timpson RL. 1994. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol. 126:151–158.
   PubMedGoogle Scholar
• Augst AD, Kong HJ, Mooney DJ. 2006. Alginate hydrogels as biomaterials. Macromol Biosci. 6:623–633.
   PubMed Web of Science ®Google Scholar
• Bidarra SJ, Barrias CC, Barbosa MA, Soares R, Granja PL. 2010. Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules. 11:1956–1964.
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs PHB, Pasi KJ. 2003. Haemophilias A and B. Lancet. 361:1801–1809.
   PubMed Web of Science ®Google Scholar
• Boudreau NJ, Jones PL. 1999. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J. 339:481–488.
   PubMed Web of Science ®Google Scholar
• Chang PL, Hortelano G, Awrey DE, Tse M. 1994. Growth of recombinant fibroblasts in alginate microcapsules. Biotechnol Bioeng. 43:925–933.
   PubMed Web of Science ®Google Scholar
• Chang PL, Shen N, Westcott AJ. 1993. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther. 4:433–440.
   PubMed Web of Science ®Google Scholar
• Chang T. 1972. Arificial Cells. Illinois USA: Charles C Thomas Springfield.
   Google Scholar
• Chang T. 2007. ARTIFICIAL CELLS: biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy. London: World Scientific Publisher/Imperial College Press.
   Google Scholar
• Check E. 2003. Harmful potential of viral vectors fuels doubts over gene therapy. Nature. 423:573–574.
   PubMed Web of Science ®Google Scholar
• Cieslinski DA, David Humes H. 1994. Tissue engineering of a bioartificial kidney. Biotechnol Bioeng. 43:678–681.
   PubMed Web of Science ®Google Scholar
• Degala S, Zipfel WR, Bonassar LJ. 2011. Chondrocyte calcium signaling in response to fluid flow is regulated by matrix adhesion in 3-D alginate scaffolds. Arch Biochem Biophys. 505:112–117.
   Google Scholar
• Drury JL, Boontheekul T, Mooney DJ. 2005. Cellular cross-linking of peptide modified hydrogels. J Biomech Eng. 127:220–228.
   PubMed Web of Science ®Google Scholar
• Duggal S, Frønsdal KB, Szöke K, Shahdadfar A, Melvik JE, Brinchmann JE. 2009. Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng Part A. 15:1763–1773.
   PubMed Web of Science ®Google Scholar
• Evangelista MB, Hsiong SX, Fernandes R, Sampaio P, Kong HJ, Barrias CC, et al. 2007. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials. 28:3644–3655.
   PubMed Web of Science ®Google Scholar
• García-Martín C, Chuah MK, Van Damme A, Robinson KE, Vanzieleghem B, Saint-Remy JM, et al. 2002. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A. J Gene Med. 4:215–223.
   PubMed Web of Science ®Google Scholar
• Gater A, Thomson TA, Strandberg-Larsen M. 2011. Haemophilia B: impact on patients and economic burden of disease. Thromb Haemost. 106:398–404.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. 1996. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:5095–5103.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Xu N, Vandenberg A, Solera J, Chang PL, Ofosu FA. 1999. Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules. Hum Gene Ther. 10:1281–1288.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Wang L, Xu N, Ofosu FA. 2001. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis. Haemophilia. 7:207–214.
   PubMed Web of Science ®Google Scholar
• Koo J, Chang TM. 1993. Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int J Artif Organs. 16:557–560.
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog Polym Sci. 37:106–126.
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science (New York, N.Y.). 210:908–910.
   PubMed Web of Science ®Google Scholar
• Liu ZC, Chang, TMS. 2012. Intrasplenic transplantation of bioencapsulated mesenchymal stem cells improves the recovery rates of 90% partial hepatectomized rats. Stem Cells Int. 2012:1–6.
   Google Scholar
• Markusen JF, Mason C, Hull DA, Town MA, Tabor AB, Clements M, et al. 2006. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng. 12:821–830.
   PubMedGoogle Scholar
• Marshall E. 2001. Gene therapy. Panel reviews risks of germ line changes. Science (New York, N.Y.). 294:2268–2269.
   Google Scholar
• Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, et al. 2011. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med. 365:2357–2365.
   PubMed Web of Science ®Google Scholar
• Orive G, De Castro M, Kong HJ, Hernández RM, Ponce S, Mooney DJ, Pedraz JL. 2009a. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release. 135:203–210.
   PubMed Web of Science ®Google Scholar
• Orive G, De Castro M, Kong HJ, Hernández RM, Ponce S, Mooney DJ, Pedraz JL. 2009b. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release. 135:203–210.
   PubMed Web of Science ®Google Scholar
• Orive G, Tam SK, Pedraz JL, Hallé JP. 2006. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials. 27:3691–3700.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernández RM, Gascón AR, Calafiore R, Chang TM, De Vos P. 2003. Cell encapsulation: promise and progress. Nat Med. 9:104–107.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernández RM, Rodríguez Gascón A, Calafiore R, Chang TM, de Vos P, et al. 2004. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 22:87–92.
   PubMed Web of Science ®Google Scholar
• Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, Shi Y. 2012. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 1:51–58.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Pierschbacher MD. 1986. Arg-Gly-Asp: a versatile cell recognition signal. Cell. 44:517–518.
   PubMed Web of Science ®Google Scholar
• Sadler J, Davie E. 1987. The metabolic basis of inherited disease. In: Hemophilia A, hemophilia B, and von Willebrand's disease. New York: W.B. Saunders, pp. 575–598.
   Google Scholar
• Sayyar B, Dodd M, Wen J, Ma S, Marquez-Curtis L, Janowska- Wieczorek A, Hortelano G. 2012. Encapsulation of factor IX–engineered mesenchymal stem cells in fibrinogen–alginate microcapsules enhances their viability and transgene secretion. J Tissue Eng. Available at: http://tej.sagepub.com/content/early/2012/11/02/2041731412462018 [Accessed November 20, 2012].
   Google Scholar
• Sheffield WP, Mamdani A, Hortelano G, Gataiance S, Eltringham-Smith L, Begbie ME, et al. 2004. Effects of genetic fusion of factor IX to albumin on in vivo clearance in mice and rabbits. Br J Haematol. 126:565–573.
   PubMed Web of Science ®Google Scholar
• Shin H, Jo S, Mikos AG. 2003. Biomimetic materials for tissue engineering. Biomaterials. 24:4353–4364.
   PubMed Web of Science ®Google Scholar
• Thakur A, Sengupta R, Matsui H, Lillicrap D, Jones K, Hortelano G. 2010. Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometry. J Biomed Mater Res B Appl Biomater. 94:296–304.
   PubMed Web of Science ®Google Scholar
• Wen J, Xu N, Li A, Bourgeois J, Ofosu FA, Hortelano G. 2007. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. J Gene Med. 9:1002–1010.
   PubMed Web of Science ®Google Scholar
• Wen J, Vargas AG, Ofosu FA, Hortelano G. 2006. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. J Gene Med. 8:362–369.
   PubMed Web of Science ®Google Scholar
• Wong H, Chang TM. 1986. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int J Artif Organs. 9:335–336.
   PubMed Web of Science ®Google Scholar